Publication | Closed Access
CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas
16
Citations
8
References
2014
Year
Our data demonstrated that HSP47 is a novel glioma-associated antigen. HSP47-based vaccine will likely confer additional survival benefit to patients with GBM after surgical treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1